InsidersTradesSigma
서울제약: directors' dealings · South Korea · DART (FSS)
DART:company-7175c5KR·DART (FSS)Mcap 35.9Bn€
Explore the full directors' dealings record of 서울제약, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Market capitalisation: €35.9bn. The latest transaction was filed on 1 April 2026 (Purchase). Among the most active insiders: 2018큐씨피13호사모투자. Every trade is openly available.
2
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2640.00 €
Income statement
Revenue52.15 Bn€
Gross profit31.50 Bn€60% margin
Net income753.6 M€1.4% margin
Balance sheet & cash
Market cap35.91 Bn€
Total debt17.39 Bn€
Free Cash Flow992.1 M€
Last declaration on 1 April 2026
Declarations2 total
Executives●Purchase2DART
8,291 shares
KRX
DART:20260331004950·
Ideal exit: 27 Dec 2026 (T+270)
2 of 2 declarations